NO914003D0 - Fremgangsmaate for fremstilling av hydroxyalkylkinolinethersyrer - Google Patents
Fremgangsmaate for fremstilling av hydroxyalkylkinolinethersyrerInfo
- Publication number
- NO914003D0 NO914003D0 NO914003A NO914003A NO914003D0 NO 914003 D0 NO914003 D0 NO 914003D0 NO 914003 A NO914003 A NO 914003A NO 914003 A NO914003 A NO 914003A NO 914003 D0 NO914003 D0 NO 914003D0
- Authority
- NO
- Norway
- Prior art keywords
- hydroxyalkylkinolinether
- acids
- procedure
- preparation
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D215/14—Radicals substituted by oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/18—Halogen atoms or nitro radicals
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Ophthalmology & Optometry (AREA)
- Pulmonology (AREA)
- Reproductive Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Quinoline Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US59688590A | 1990-10-12 | 1990-10-12 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO914003D0 true NO914003D0 (no) | 1991-10-11 |
| NO914003L NO914003L (no) | 1992-04-13 |
Family
ID=24389130
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO91914003A NO914003L (no) | 1990-10-12 | 1991-10-11 | Fremgangsmaate for fremstilling av hydroxyalkylkinolinethersyrer som leukotrienantagonister |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP0480708B1 (no) |
| JP (1) | JP2538154B2 (no) |
| KR (1) | KR920008005A (no) |
| CN (1) | CN1061594A (no) |
| AT (1) | ATE128969T1 (no) |
| AU (1) | AU639612B2 (no) |
| CA (1) | CA2053208C (no) |
| CS (1) | CS309491A3 (no) |
| DE (1) | DE69113735T2 (no) |
| ES (1) | ES2079586T3 (no) |
| FI (1) | FI914795L (no) |
| HU (1) | HUT61982A (no) |
| IE (1) | IE913610A1 (no) |
| IL (1) | IL99683A0 (no) |
| MX (1) | MX9101556A (no) |
| NO (1) | NO914003L (no) |
| PT (1) | PT99211B (no) |
| ZA (1) | ZA918115B (no) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5506227A (en) * | 1992-04-13 | 1996-04-09 | Merck Frosst Canada, Inc. | Pyridine-substituted benzyl alcohols as leukotriene antagonists |
| US5358955A (en) * | 1992-10-30 | 1994-10-25 | Abbott Laboratories | Aryl and heteroarylmethoxyphenyl inhibitors of leukotriene biosynthesis |
| US5438141A (en) * | 1993-05-21 | 1995-08-01 | Merck Frosst Canada, Inc. | Heteroaryl and haloaryl quinoline derivatives of cyclopropaneacetic acid as leukotriene antagonists |
| JPH09278653A (ja) * | 1996-04-05 | 1997-10-28 | Santen Pharmaceut Co Ltd | 網膜疾患治療剤 |
| AU3868497A (en) * | 1996-08-26 | 1998-03-19 | Yamanouchi Pharmaceutical Co., Ltd. | Benzenesulfone compounds and salts thereof |
| GB2356139A (en) * | 1999-11-15 | 2001-05-16 | Bayer Ag | Use of substituted (quinolin-2-yl-methoxy)phenyl-acyl-sulphonamides and cyanamides for the treatment of diseases |
| EP1958936A1 (en) * | 2007-02-14 | 2008-08-20 | Inke, S.A. | Process for obtaining montelukast |
| AU2012320010B2 (en) * | 2011-07-26 | 2017-03-30 | Sun Pharma Advanced Research Company Ltd. | Quinoline-, quinoxaline or benzothiazole based cysteinyl leukotriene antagonists (LTD4) |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS62120365A (ja) * | 1985-11-16 | 1987-06-01 | バイエル・アクチエンゲゼルシヤフト | 置換ベンジルエ−テル類、その製造法および用途 |
| IE59889B1 (en) * | 1986-02-14 | 1994-04-20 | Merck Frosst Canada Inc | 2-substituted quinoline dioic acids |
| JPS62258369A (ja) * | 1986-05-02 | 1987-11-10 | Nippon Soda Co Ltd | キナゾリノン誘導体及びその製造方法 |
| EP0271287A3 (en) * | 1986-12-11 | 1990-06-13 | Merck Frosst Canada Inc. | Quinoline dioic acids and amides |
| IL88433A0 (en) * | 1987-11-25 | 1989-06-30 | Merck Frosst Canada Inc | Diarylstyrylquinoline diacids and pharmaceutical compositions containing them |
| EP0349062A1 (en) * | 1988-06-27 | 1990-01-03 | Merck Frosst Canada Inc. | Quinoline ether alkanoic acid |
| NZ233752A (en) * | 1989-05-24 | 1993-05-26 | Merck Frosst Canada Inc | Substituted quinoline derivatives, preparation and pharmaceutical compositions thereof |
-
1991
- 1991-10-09 AT AT91309289T patent/ATE128969T1/de not_active IP Right Cessation
- 1991-10-09 DE DE69113735T patent/DE69113735T2/de not_active Expired - Fee Related
- 1991-10-09 EP EP91309289A patent/EP0480708B1/en not_active Expired - Lifetime
- 1991-10-09 IL IL99683A patent/IL99683A0/xx unknown
- 1991-10-09 ES ES91309289T patent/ES2079586T3/es not_active Expired - Lifetime
- 1991-10-10 HU HU913218A patent/HUT61982A/hu unknown
- 1991-10-10 CA CA002053208A patent/CA2053208C/en not_active Expired - Fee Related
- 1991-10-11 CS CS913094A patent/CS309491A3/cs unknown
- 1991-10-11 NO NO91914003A patent/NO914003L/no unknown
- 1991-10-11 PT PT99211A patent/PT99211B/pt not_active IP Right Cessation
- 1991-10-11 FI FI914795A patent/FI914795L/fi not_active Application Discontinuation
- 1991-10-11 ZA ZA918115A patent/ZA918115B/xx unknown
- 1991-10-11 CN CN91111074A patent/CN1061594A/zh active Pending
- 1991-10-11 MX MX9101556A patent/MX9101556A/es unknown
- 1991-10-11 AU AU85797/91A patent/AU639612B2/en not_active Ceased
- 1991-10-12 KR KR1019910017952A patent/KR920008005A/ko not_active Withdrawn
- 1991-10-14 JP JP3331108A patent/JP2538154B2/ja not_active Expired - Lifetime
- 1991-10-16 IE IE361091A patent/IE913610A1/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AU639612B2 (en) | 1993-07-29 |
| CA2053208C (en) | 2003-04-15 |
| ES2079586T3 (es) | 1996-01-16 |
| IL99683A0 (en) | 1992-08-18 |
| EP0480708A3 (en) | 1992-05-20 |
| CS309491A3 (en) | 1992-04-15 |
| DE69113735D1 (de) | 1995-11-16 |
| NO914003L (no) | 1992-04-13 |
| JPH05105664A (ja) | 1993-04-27 |
| HUT61982A (en) | 1993-03-29 |
| EP0480708B1 (en) | 1995-10-11 |
| FI914795A0 (fi) | 1991-10-11 |
| HU913218D0 (en) | 1992-01-28 |
| FI914795A7 (fi) | 1992-04-13 |
| CN1061594A (zh) | 1992-06-03 |
| IE913610A1 (en) | 1992-04-22 |
| AU8579791A (en) | 1992-04-16 |
| FI914795L (fi) | 1992-04-13 |
| JP2538154B2 (ja) | 1996-09-25 |
| CA2053208A1 (en) | 1992-04-13 |
| EP0480708A2 (en) | 1992-04-15 |
| MX9101556A (es) | 1994-01-31 |
| PT99211B (pt) | 1999-04-30 |
| PT99211A (pt) | 1992-09-30 |
| DE69113735T2 (de) | 1996-06-13 |
| ZA918115B (en) | 1992-08-26 |
| KR920008005A (ko) | 1992-05-27 |
| ATE128969T1 (de) | 1995-10-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO914004D0 (no) | Fremgangsmaate for fremstilling av umettede hydroxyalkylkinolinsyrer | |
| FI944734A0 (fi) | Kinoliinijohdannaiset leukotrieeniantagonisteina | |
| FI920734A0 (fi) | Ketosyror innehaollande kinoliner med leukotrienantagonisteffekt. | |
| NO952495L (no) | Diaryl-5,6-kondenserte heterosykliske syrer som leukotrienantagonister | |
| NO914003D0 (no) | Fremgangsmaate for fremstilling av hydroxyalkylkinolinethersyrer | |
| MY107767A (en) | Fluorinated hydroxyalkylquinoline acids as leukotriene antagonists |